University at Buffalo (UB)
Updated September 22, 2017 This content is archived.
Research by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, shows that patients with type 1 diabetes who were treated with a type 2 diabetes drug had a significant decline in their blood sugar levels. “There remains a high unmet medical need in helping treat the millions of patients living with type 1 diabetes while managing the complications associated with the disease,” he said. “It is critical that we continue to advance clinical research with newer and novel therapies.”